You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Baxter
Colorcon
Express Scripts
Moodys

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

FEXOFENADINE HYDROCHLORIDE HIVES Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Fexofenadine Hydrochloride Hives patents expire, and what generic alternatives are available?

Fexofenadine Hydrochloride Hives is a drug marketed by Dr Reddys Labs Ltd, Mylan, Sciegen Pharms Inc, Sun Pharm Inds, Teva, and Wockhardt Ltd. and is included in six NDAs.

The generic ingredient in FEXOFENADINE HYDROCHLORIDE HIVES is fexofenadine hydrochloride. There are twenty-three drug master file entries for this compound. One hundred and two suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Fexofenadine Hydrochloride Hives

A generic version of FEXOFENADINE HYDROCHLORIDE HIVES was approved as fexofenadine hydrochloride by TEVA on September 1st, 2005.

  Start Trial

Summary for FEXOFENADINE HYDROCHLORIDE HIVES
Drug patent expirations by year for FEXOFENADINE HYDROCHLORIDE HIVES
Recent Clinical Trials for FEXOFENADINE HYDROCHLORIDE HIVES

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tanta UniversityPhase 4
Assistance Publique - Hôpitaux de ParisPhase 4
BayerPhase 1

See all FEXOFENADINE HYDROCHLORIDE HIVES clinical trials

Pharmacology for FEXOFENADINE HYDROCHLORIDE HIVES

US Patents and Regulatory Information for FEXOFENADINE HYDROCHLORIDE HIVES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd FEXOFENADINE HYDROCHLORIDE HIVES fexofenadine hydrochloride TABLET;ORAL 076502-007 Apr 12, 2011 OTC No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds FEXOFENADINE HYDROCHLORIDE HIVES fexofenadine hydrochloride TABLET;ORAL 091567-003 Feb 6, 2012 OTC No No   Start Trial   Start Trial   Start Trial
Mylan FEXOFENADINE HYDROCHLORIDE HIVES fexofenadine hydrochloride TABLET;ORAL 077081-009 Jul 21, 2011 OTC No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds FEXOFENADINE HYDROCHLORIDE HIVES fexofenadine hydrochloride TABLET;ORAL 091567-005 Feb 6, 2012 OTC No No   Start Trial   Start Trial   Start Trial
Dr Reddys Labs Ltd FEXOFENADINE HYDROCHLORIDE HIVES fexofenadine hydrochloride TABLET;ORAL 076502-009 Apr 12, 2011 OTC No No   Start Trial   Start Trial   Start Trial
Mylan FEXOFENADINE HYDROCHLORIDE HIVES fexofenadine hydrochloride TABLET;ORAL 077081-007 Jul 21, 2011 OTC No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Merck
Express Scripts
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.